Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04720430 · ClinicalTrials.gov registry record

Blood Sample Collection for Experimental Blood Test to Track Liver Cancer

A clinical trial, sponsored by Thomas Jefferson University.

Completed
Registry status
7
Enrollment target

NCT04720430 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04720430 has completed, sponsored by Thomas Jefferson University.

COMPLETED
Registry status
7 participants
Enrollment target

Study Summary

This study investigates if an experimental blood test can help predict how well cancer will remain under control with treatment. Ther experimental blood test involves measuring mircoRNAs. MicroRNAs are small molecules which help regulate how genes are expressed. This information may help researchers guide treatment for other patients in the future.

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2019-12-03
Est. Completion 2023-11-09

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT04720430

The ClinicalTrials.gov registry entry for NCT04720430 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04720430 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04720430 about?

NCT04720430 is a clinical study titled "Blood Sample Collection for Experimental Blood Test to Track Liver Cancer". This study investigates if an experimental blood test can help predict how well cancer will remain under control with treatment. Ther experimental blood test involves measuring mircoRNAs. MicroRNAs are small molecules which help regulate how genes are expressed. This information may help researchers...

What is the current status of trial NCT04720430?

This trial is currently completed. The enrollment target is 7 participants. The study started on 2019-12-03. Estimated completion is 2023-11-09.

Who is sponsoring clinical trial NCT04720430?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.